Overview

A Clinical Trial to Evaluate the Safety and Efficacy of DR-2041(Synthetic Conjugated Estrogens, A) for Treatment of Vulvovaginal Atrophy

Status:
Completed

Trial end date:
2007-09-01

Target enrollment:

Participant gender:

Summary

This is a four-arm, randomized, double-blind, parallel group, placebo-controlled study to compare the effects of two doses of DR-2041(Synthetic Conjugated Estrogens, A) Vaginal Cream on vulvovaginal atrophy in postmenopausal women with or without a hysterectomy and/or oophorectomy.

Phase:

Phase 3

Details

Lead Sponsor:

Duramed Research

Treatments:

Estrogens
Estrogens, Conjugated (USP)
Estrogens, conjugated synthetic A